Efficacy and Safety of Sirolimus in COVID-19 Infection
Status:
Recruiting
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
This research is planned to illustrate the efficacy and safety of sirolimus as an adjuvant
agent to the standard treatment protocol against COVID-19 infection